Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of CFTR Function in Human Nasal Epithelial Cells Informs Personalized Medicine.
Pion A, Kavanagh E, Joynt AT, Raraigh KS, Vanscoy L, Langfelder-Schwind E, McNamara J, Moore B, Patel S, Merlo K, Temme R, Capurro V, Pesce E, Merlo C, Pedemonte N, Cutting GR, Sharma N. Pion A, et al. Among authors: merlo k, merlo c. Am J Respir Cell Mol Biol. 2024 Nov;71(5):577-588. doi: 10.1165/rcmb.2023-0398OC. Am J Respir Cell Mol Biol. 2024. PMID: 39012815
Use of adenine base editing and homology-independent targeted integration strategies to correct the cystic fibrosis causing variant, W1282X.
Mention K, Cavusoglu-Doran K, Joynt AT, Santos L, Sanz D, Eastman AC, Merlo C, Langfelder-Schwind E, Scallan MF, Farinha CM, Cutting GR, Sharma N, Harrison PT. Mention K, et al. Among authors: merlo c. Hum Mol Genet. 2023 Nov 17;32(23):3237-3248. doi: 10.1093/hmg/ddad143. Hum Mol Genet. 2023. PMID: 37649273 Free PMC article.
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A; VX18-121-101; VX18-561-101 Study Groups. Uluer AZ, et al. Lancet Respir Med. 2023 Jun;11(6):550-562. doi: 10.1016/S2213-2600(22)00504-5. Epub 2023 Feb 23. Lancet Respir Med. 2023. PMID: 36842446 Free article. Clinical Trial.
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
Iasella CJ, Hannan SJ, Lyons EJ, Lieber SC, Das A, Dimitrov D, Li W, Saul M, Popescu I, Koshy R, Burke R, Lape B, Brown MJ, Chen X, Sembrat JC, Devonshire K, Kitsios GD, Konstantinidis I, Snyder ME, Chen BB, Merlo CA, Hager DN, Kiss JE, Yazer MH, Wells AH, Morris A, McVerry BJ, McMahon DK, Triulzi DJ, McDyer JF. Iasella CJ, et al. Among authors: merlo ca. PLoS One. 2024 Oct 24;19(10):e0309449. doi: 10.1371/journal.pone.0309449. eCollection 2024. PLoS One. 2024. PMID: 39446792 Free PMC article.
Cystic fibrosis foundation position paper: Redefining the CF care model.
Goetz DM, Brown RF, Filigno SS, Bichl SL, Nelson AL, Merlo CA, Juel R, Lomas P, Hempstead SE, Tran Q, Brown AW, Flume PA; CFF Care Model Committee. Goetz DM, et al. Among authors: merlo ca. J Cyst Fibros. 2024 Nov;23(6):1055-1065. doi: 10.1016/j.jcf.2024.08.007. Epub 2024 Sep 25. J Cyst Fibros. 2024. PMID: 39327191 Free article. Review.
252 results